MedPath
NMPA Approval

Ozagrel Sodium for Injection

国药准字H20041260

September 11, 2020

Drug Information

注射用奥扎格雷钠

注射剂

20mg(按C13H11N2NaO2计)

化学药品

September 11, 2020

Company Information

Manufacturing Company

吉林省磐石经济开发区西点大街777号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用奥扎格雷钠 - NMPA 批准文号 | MedPath